{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:49:13Z","timestamp":1785170953633,"version":"3.55.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"abstract":"<jats:sec>\n            <jats:title>Context:<\/jats:title>\n            <jats:p>Health care professionals must continually identify collaborative ways to combat antibiotic resistance while improving community health and health care delivery. Clinical Laboratory Improvement Amendments of 1988 (CLIA)-waived point-of-care (POC) testing (POCT) services for infectious disease conducted in community pharmacies provide a means for pharmacists to collaborate with prescribers and\/or public health officials combating antibiotic resistance while improving community health and health care delivery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>To provide a comprehensive literature review that explores the potential for pharmacists to collaborate with public health professionals and prescribers using pharmacy-based CLIA-waived POCT services for infectious diseases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Comprehensive literature review.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>PubMed and Google Scholar were searched for manuscripts and meeting abstracts for the following key words: infectious disease, community pharmacy, rapid diagnostic tests, rapid assay, and POC tests.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Intervention:<\/jats:title>\n            <jats:p>All relevant manuscripts and meeting abstracts utilizing POCT in community pharmacies for infectious disease were reviewed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcome Measure:<\/jats:title>\n            <jats:p>Information regarding the most contemporary evidence regarding CLIA-waived POC infectious diseases tests for infectious diseases and their use in community pharmacies was synthesized to highlight and identify opportunities to develop future collaborations using community pharmacy-based models for such services.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Evidence demonstrates that pharmacists in collaboration with other health care professionals can leverage their knowledge and accessibility to provide CLIA-waived POCT services for infectious diseases. Testing for influenza may augment health departments' surveillance efforts, help promote rationale antiviral use, and avoid unnecessary antimicrobial therapy. Services for human immunodeficiency virus infection raise infection status awareness, increase access to health care, and facilitate linkage to appropriate care. Testing for group A streptococcal pharyngitis may curb inappropriate outpatient antibiotic prescribing. However, variance in pharmacy practice statues and the application of CLIA across states stifle collaboration.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>CLIA-waived POCT services for infectious diseases are a means for pharmacists, public health professionals, and prescribers to collaboratively combat antibiotic resistance and improve community health.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/phh.0000000000000482","type":"journal-article","created":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T23:04:00Z","timestamp":1482015840000},"page":"593-600","source":"Crossref","is-referenced-by-count":31,"title":["Potential for Pharmacy\u2013Public Health Collaborations Using Pharmacy-Based Point-of-Care Testing Services for Infectious Diseases"],"prefix":"10.1097","volume":"23","author":[{"given":"Paul O.","family":"Gubbins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Klepser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex J.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly M.","family":"Percival","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory B.","family":"Tallman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20230929","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1586\/14737159.2015.1116388","article-title":"Use of CLIA-waived point-of-care tests for infectious diseases in community pharmacies in the United States","volume":"16","author":"Weber","year":"2016","journal-title":"Exp Rev Mol Diagn."},{"key":"R4-20230929","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/PHH.0000000000000276","article-title":"Public health perceptions of community pharmacy partnership opportunities","volume":"21","author":"Roberts","year":"2015","journal-title":"J Public Health Manag Pract."},{"key":"R5-20230929","first-page":"e923","article-title":"Physician-pharmacist collaborative practice agreements: a strategy to improve adherence to evidence-based guidelines","volume":"1","author":"Adams","year":"2015","journal-title":"Evid Based Med Public Health."},{"key":"R6-20230929","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1089\/bsp.2013.0082","article-title":"Leveraging partnerships among community pharmacists, pharmacies, and health departments to improve pandemic influenza response","volume":"12","author":"Rubin","year":"2014","journal-title":"Biosecur Bioterror."},{"key":"R7-20230929","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1331\/JAPhA.2014.13167","article-title":"Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy","volume":"54","author":"Gubbins","year":"2014","journal-title":"J Am Pharm Assoc."},{"issue":"RR-13","key":"R8-20230929","first-page":"1","article-title":"Good laboratory practices for waived testing sites; survey findings from testing sites holding a certificate of waiver under the Clinical Laboratory Improvement Amendments of 1988 and recommendations for promoting quality testing","volume":"54","year":"2005","journal-title":"MMWR Recomm Rep."},{"key":"R9-20230929","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/irv.12246","article-title":"Analytical reactivity of 13 commercially available rapid influenza diagnostic tests with H3N2v and recently circulating influenza viruses","volume":"8","author":"Bose","year":"2014","journal-title":"Influenza Other Respir Viruses."},{"key":"R10-20230929","doi-asserted-by":"crossref","first-page":"500","DOI":"10.7326\/0003-4819-156-7-201204030-00403","article-title":"Accuracy of rapid influenza diagnostic tests: a meta-analysis","volume":"156","author":"Chartrand","year":"2012","journal-title":"Ann Intern Med."},{"key":"R11-20230929","doi-asserted-by":"crossref","first-page":"287269","DOI":"10.1155\/2013\/287269","article-title":"Rapid point-of-care testing for detection of HIV and clinical monitoring","volume":"2013","author":"Arora","year":"2013","journal-title":"ISRN AIDS."},{"key":"R12-20230929","doi-asserted-by":"crossref","first-page":"e1001306","DOI":"10.1371\/journal.pmed.1001306","article-title":"Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low-and middle-income countries","volume":"9","author":"Pai","year":"2012","journal-title":"PLoS Med."},{"key":"R13-20230929","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1542\/peds.2014-1094","article-title":"Rapid diagnostic tests for group A streptococcal pharyngitis: a meta-analysis","volume":"134","author":"Lean","year":"2014","journal-title":"Pediatrics."},{"key":"R14-20230929","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/cid\/cis847","article-title":"Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America","volume":"55","author":"Shulman","year":"2012","journal-title":"Clin Infect Dis."},{"key":"R15-20230929","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/M15-1840","article-title":"Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American College of Physicians and the Centers for Disease Control and Prevention","volume":"164","author":"Harris","year":"2016","journal-title":"Ann Intern Med."},{"key":"R16-20230929","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.3851\/IMP2470","article-title":"Rapid diagnostic HCV antibody assays","volume":"17","author":"Smith","year":"2012","journal-title":"Antivir Ther."},{"issue":"4","key":"R17-20230929","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.sapharm.2015.09.006","article-title":"U.S. community pharmacies as CLIA-waived facilities: prevalence, dispersion, and impact on patient access to testing","volume":"12","author":"Klepser","year":"2016","journal-title":"Res Social Adm Pharm."},{"key":"R18-20230929","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1370\/afm.1542","article-title":"Vaccinations administered during off-clinic hours at a national community pharmacy: implications for increasing patient access and convenience","volume":"11","author":"Goad","year":"2013","journal-title":"Ann Fam Med."},{"key":"R20-20230929","first-page":"781","article-title":"Place of influenza vaccination among adults: United States, 2010-11 influenza season","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"R22-20230929","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.japh.2015.11.008","article-title":"Effectiveness of a pharmacist-physician collaborative program to manage influenza-like illness","volume":"56","author":"Klepser","year":"2016","journal-title":"J Am Pharm Assoc."},{"issue":"2","key":"R23-20230929","doi-asserted-by":"crossref","DOI":"10.24926\/iip.v5i2.341","article-title":"Time and motion study of influenza diagnostic testing in a community pharmacy","volume":"5","author":"Klepser","year":"2014","journal-title":"Innov Pharm."},{"key":"R24-20230929","doi-asserted-by":"crossref","first-page":"568","DOI":"10.18553\/jmcp.2015.21.7.568","article-title":"Health care resource utilization and costs for influenza-like illness among Midwestern health plan members","volume":"21","author":"Klepser","year":"2015","journal-title":"J Manage Care Spec Pharm."},{"key":"R26-20230929","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/apc.2013.0076","article-title":"Counselor-based rapid HIV testing in community pharmacies","volume":"27","author":"Calderon","year":"2013","journal-title":"AIDS Patient Care STDs."},{"key":"R27-20230929","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1331\/JAPhA.2014.14045","article-title":"HIV testing in community pharmacies and retail clinics: a model to expand access to screening for HIV infection","volume":"54","author":"Weidle","year":"2014","journal-title":"J Am Pharm Assoc."},{"key":"R28-20230929","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1331\/JAPhA.2015.150630","article-title":"Cost analysis of a novel HIV testing strategy in community pharmacies and retail clinics","volume":"55","author":"Lecher","year":"2015","journal-title":"J Am Pharm Assoc."},{"key":"R29-20230929","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1331\/JAPhA.2015.14070","article-title":"Pharmacist-provided rapid HIV testing in two community pharmacies","volume":"55","author":"Darin","year":"2015","journal-title":"J Am Pharm Assoc."},{"key":"R30-20230929","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1331\/JAPhA.2015.14069","article-title":"Consumer interest in community pharmacy HIV screening services","volume":"55","author":"Darin","year":"2015","journal-title":"J Am Pharm Assoc."},{"key":"R31-20230929","first-page":"1","article-title":"Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"R32-20230929","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.japh.2015.11.013","article-title":"Antimicrobial stewardship in outpatient settings: community pharmacist-physician collaborative streptococcal pharyngitis management program","volume":"56","author":"Klepser","year":"2016","journal-title":"J Am Pharm Assoc."},{"key":"R33-20230929","first-page":"75","article-title":"A clinical score to reduce unnecessary antibiotic use in patients with sore throat","volume":"158","author":"McIsaac","year":"1998","journal-title":"Can Med Assoc J."},{"key":"R34-20230929","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1001\/jama.291.13.1587","article-title":"Empirical validation of guidelines for the management of pharyngitis in children and adults","volume":"291","author":"McIsaac","year":"2004","journal-title":"JAMA."},{"key":"R35-20230929","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1001\/jamainternmed.2013.11673","article-title":"Antibiotic prescribing to adults with sore throat in the United States, 1997-2010","volume":"174","author":"Barnett","year":"2014","journal-title":"JAMA Intern Med."},{"key":"R36-20230929","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cptl.2014.09.012","article-title":"Assessment of pharmacy students' and licensed pharmacists' perceived knowledge, application, and interpretation regarding rapid diagnostic tests (RDTs) for infectious diseases","volume":"7","author":"Daunais","year":"2015","journal-title":"Curr Pharm Teach Learn."},{"key":"R37-20230929","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cptl.2014.09.005","article-title":"Pharmacy-based point-of-care testing for infectious diseases: considerations for the pharmacy curriculum","volume":"7","author":"Akinwale","year":"2015","journal-title":"Curr Pharm Teach Learn."},{"key":"R38-20230929","first-page":"1","article-title":"Quantification of curricular content devoted to point-of care testing for infectious diseases in schools and colleges of pharmacy in the United States","volume":"15","author":"Huang","year":"2015","journal-title":"Pharm Ed."}],"container-title":["Journal of Public Health Management and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00124784-201711000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T06:01:52Z","timestamp":1695967312000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00124784-201711000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/phh.0000000000000482","relation":{},"ISSN":["1078-4659"],"issn-type":[{"value":"1078-4659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}